These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 36256597)

  • 1. Ventricular arrhythmias in arrhythmic mitral valve syndrome-a prospective continuous long-term cardiac monitoring study.
    Aabel EW; Chivulescu M; Lie ØH; Hopp E; Gjertsen E; Ribe M; Helle-Valle TM; Edvardsen T; Hegbom F; Dejgaard LA; Haugaa KH
    Europace; 2023 Feb; 25(2):506-516. PubMed ID: 36256597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Mitral Annulus Disjunction Arrhythmic Syndrome.
    Dejgaard LA; Skjølsvik ET; Lie ØH; Ribe M; Stokke MK; Hegbom F; Scheirlynck ES; Gjertsen E; Andresen K; Helle-Valle TM; Hopp E; Edvardsen T; Haugaa KH
    J Am Coll Cardiol; 2018 Oct; 72(14):1600-1609. PubMed ID: 30261961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitral valve prolapse: arrhythmic risk during pregnancy and postpartum.
    Sabbag A; Aabel EW; Castrini AI; Siontis KC; Laredo M; Nizard J; Duthoit G; Asirvatham S; Sehrawat O; Kirkels FP; van Rosendael PJ; Beinart R; Acha MR; Peichl P; Lim HS; Sohns C; Martins R; Font J; Truong NNK; Estensen M; Haugaa KH
    Eur Heart J; 2024 May; 45(20):1831-1839. PubMed ID: 38740526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presentation and Outcome of Arrhythmic Mitral Valve Prolapse.
    Essayagh B; Sabbag A; Antoine C; Benfari G; Yang LT; Maalouf J; Asirvatham S; Michelena H; Enriquez-Sarano M
    J Am Coll Cardiol; 2020 Aug; 76(6):637-649. PubMed ID: 32762897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arrhythmic Risk Stratification in Patients With Idiopathic Dilated Cardiomyopathy.
    Stolfo D; Ceschia N; Zecchin M; De Luca A; Gobbo M; Barbati G; Gigli M; Masè M; Pinamonti B; Pivetta A; Merlo M; Sinagra G
    Am J Cardiol; 2018 Jun; 121(12):1601-1609. PubMed ID: 29678335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitral Annular Substrate and Ventricular Arrhythmias in Arrhythmogenic Mitral Valve Prolapse With Mitral Annular Disjunction.
    Chakrabarti AK; Deshmukh A; Liang JJ; Madamanchi C; Ghannam M; Morady F; Bogun F
    JACC Clin Electrophysiol; 2023 Aug; 9(8 Pt 1):1265-1275. PubMed ID: 37086231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sudden cardiac arrest in ventricular fibrillation mechanism as a first manifestation of primary mitral valve prolapse].
    Brzyzkiewicz H; Wałek P; Janion M
    Przegl Lek; 2012; 69(12):1306-8. PubMed ID: 23750446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study.
    Grimm W; Christ M; Bach J; Müller HH; Maisch B
    Circulation; 2003 Dec; 108(23):2883-91. PubMed ID: 14623812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessment.
    Cappelletto C; Stolfo D; De Luca A; Pinamonti B; Barbati G; Pivetta A; Gobbo M; Brun F; Merlo M; Sinagra G
    Europace; 2018 Jun; 20(FI1):f20-f29. PubMed ID: 28633348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of the risk stratification proposed by the 2022 European Heart Rhythm Association Expert Consensus statement on arrhythmic mitral valve prolapse.
    L'Hoyes W; Robyns T; Moura-Fereira S; De Meester P; Dresselaers T; Herregods MC; Rega F; Masci PG; Willems R; Bogaert J; Vandenberk B
    Am Heart J; 2023 Dec; 266():48-60. PubMed ID: 37595658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ventricular arrhythmias : What has been confirmed in therapy?].
    Duncker D; Bauersachs J; Veltmann C
    Internist (Berl); 2017 Dec; 58(12):1272-1280. PubMed ID: 29071387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication.
    Schaer B; Kühne M; Reichlin T; Osswald S; Sticherling C
    Europace; 2016 Feb; 18(2):227-31. PubMed ID: 26063686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy.
    Zorzi A; Rigato I; Pilichou K; Perazzolo Marra M; Migliore F; Mazzotti E; Gregori D; Thiene G; Daliento L; Iliceto S; Rampazzo A; Basso C; Bauce B; Corrado D
    Europace; 2016 Jul; 18(7):1086-94. PubMed ID: 26138720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis.
    Aizer A; Stern EH; Gomes JA; Teirstein AS; Eckart RE; Mehta D
    Am J Cardiol; 2005 Jul; 96(2):276-82. PubMed ID: 16018857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lifetime exercise dose and ventricular arrhythmias in patients with mitral valve prolapse.
    Five CK; Hasselberg NE; Aaserud LT; Castrini AI; Vlaisavljevic K; Lie Ø; Rootwelt-Norberg C; Aabel EW; Haugaa KH
    Europace; 2023 Oct; 25(10):. PubMed ID: 37851515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Mitral Annular Disjunction of Mitral Valve Prolapse: Presentation and Outcome.
    Essayagh B; Sabbag A; Antoine C; Benfari G; Batista R; Yang LT; Maalouf J; Thapa P; Asirvatham S; Michelena HI; Enriquez-Sarano M
    JACC Cardiovasc Imaging; 2021 Nov; 14(11):2073-2087. PubMed ID: 34147457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bileaflet Mitral Valve Prolapse and Risk of Ventricular Dysrhythmias and Death.
    Nordhues BD; Siontis KC; Scott CG; Nkomo VT; Ackerman MJ; Asirvatham SJ; Noseworthy PA
    J Cardiovasc Electrophysiol; 2016 Apr; 27(4):463-8. PubMed ID: 26749260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of ventricular tachyarrhythmia : Any changes in the past decades?
    Jong-Ming Pang B; Green MS
    Herzschrittmacherther Elektrophysiol; 2017 Jun; 28(2):143-148. PubMed ID: 28484840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.
    Perazzolo Marra M; De Lazzari M; Zorzi A; Migliore F; Zilio F; Calore C; Vettor G; Tona F; Tarantini G; Cacciavillani L; Corbetti F; Giorgi B; Miotto D; Thiene G; Basso C; Iliceto S; Corrado D
    Heart Rhythm; 2014 May; 11(5):856-63. PubMed ID: 24440822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
    Anselme F; Moubarak G; Savouré A; Godin B; Borz B; Drouin-Garraud V; Gay A
    Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.